NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 56 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,760 | -99.9% | 3,000 | -99.9% | 0.00% | -100.0% |
| Q4 2020 | $8,177,000 | +25.1% | 5,931,000 | +25.3% | 0.17% | +20.8% |
| Q3 2020 | $6,536,000 | -4.4% | 4,733,000 | +15.2% | 0.14% | -10.0% |
| Q2 2020 | $6,839,000 | +23.7% | 4,110,000 | -4.6% | 0.16% | +33.3% |
| Q1 2020 | $5,530,000 | -20.5% | 4,310,000 | -5.0% | 0.12% | -11.1% |
| Q4 2019 | $6,957,000 | -52.5% | 4,537,000 | -57.5% | 0.14% | -50.7% |
| Q3 2019 | $14,633,000 | -4.0% | 10,683,000 | -7.5% | 0.27% | -7.1% |
| Q2 2019 | $15,247,000 | -2.6% | 11,543,000 | -0.1% | 0.30% | -14.5% |
| Q1 2019 | $15,650,000 | +11.7% | 11,558,000 | -1.7% | 0.34% | +1.8% |
| Q4 2018 | $14,016,000 | -13.6% | 11,756,000 | +23.8% | 0.34% | +1.5% |
| Q3 2018 | $16,214,000 | -2.4% | 9,495,000 | -17.1% | 0.33% | -4.6% |
| Q2 2018 | $16,612,000 | – | 11,448,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |